Sign in

CIK 0001726445

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SEER
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821153150
Phone
+1 650-453-0000
Business address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
Former names
Seer Biosciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,578
in 1 filing

Net −$3,578. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Endweiss Charles −$4K VP Financial Planning Analysis sold 2% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-01 Invus Public Equities, L.P. 10% owner Sale −252,545 $64.15 $16.2M 5,588,366
2020-12-08 Invus Public Equities, L.P. 10% owner Conversion +5,050,911 5,050,911
2020-12-08 Invus Public Equities, L.P. 10% owner Purchase +790,000 $19.00 $15.0M 5,840,911
2020-12-08 Invus Public Equities, L.P. 10% owner Conversion · Series B Convertible Preferred Stock −3,953,381 0
2020-12-08 Invus Public Equities, L.P. 10% owner Conversion · Series C Convertible Preferred Stock −373,831 0
2020-12-08 Invus Public Equities, L.P. 10% owner Conversion · Series D Convertible Preferred Stock −474,478 0
2020-12-08 Invus Public Equities, L.P. 10% owner Conversion · Series D-1 Convertible Preferred Stock −249,221 0

Page 1 of 1 · 7 trades